Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BRCA1 promoter methylation in peripheral blood is associated with the risk of triple‐negative breast cancer

30 Aug 2019

Abstract excerpt

Methylation of the promoter of the BRCA1 gene in DNA derived from peripheral blood cells is a possible risk factor for breast cancer. It is not clear if this association is restricted to certain types of breast cancer or is a general phenomenon. We evaluated BRCA1 methylation status in peripheral blood cells from 942 breast cancer patients and from 500 controls. We also assessed methylation status in 262...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA gene mutations in cancer
Share to Epigenetics and DNA Methylation
Share to Prenatal Screening and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31469414
DOI: 10.1002/ijc.32655

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BRCA1 promoter methylation in peripheral blood is associated with the risk of triple‐negative breast cancerPMID 31469414Read ↗

BRCA1 promoter methylation in peripheral blood cells is associated with increased risk of breast cancer with BRCA1 promoter methylation.Semantic proximity Read ↗

Comprehensive molecular comparison of BRCA1 hypermethylated and BRCA1 mutated triple negative breast cancers.Semantic proximity Read ↗

Constitutional methylation of the BRCA1 promoter is specifically associated with BRCA1 mutation-associated pathology in early-onset breast cancer.Semantic proximity Read ↗

BRCA1 promoter methylation in peripheral blood DNA of mutation negative familial breast cancer patients with a BRCA1 tumour phenotype.Semantic proximity Read ↗

Methylation-related mutations in the BRCA1 promoter in peripheral blood cells from cancer-free women.Semantic proximity Read ↗

BRCA1 deficiency is a recurrent event in early-onset triple-negative breast cancer: a comprehensive analysis of germline mutations and somatic promoter methylationSemantic proximity Read ↗

BRCA1 promoter methylation in peripheral blood DNA was identified in sporadic breast cancer and controls.Semantic proximity Read ↗

BRCA1 promoter methylation is a marker of better response to anthracycline-based therapy in sporadic TNBC.Semantic proximity Read ↗

DNA methylation biomarkers for the diagnosis and treatment management of breast cancer: where are we now?Semantic proximity Read ↗

Blood DNA methylation biomarkers for breast cancer riskSemantic proximity Read ↗

<em>BRAC1</em> & <em>BRCA2</em> Methylation as a Prognostic and Predictive Biomarker in Cancer: Implementation in Liquid Biopsy in the Era of Precision MedicineSemantic proximity Read ↗

The DNA methylation landscape of primary triple-negative breast cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.